Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review

被引:0
|
作者
Muir, Jeffrey M. [1 ]
Radhakrishnan, Amruta [1 ]
Stillman, Ipek Ozer [2 ]
Sarri, Grammati [3 ]
机构
[1] Cytel Inc, RWA Hlth Econ, Toronto, ON, Canada
[2] Takeda Pharmaceut, Value Evidence & Hlth Econ, Lexington, MA USA
[3] Cytel Inc, RWA Hlth Econ, London, England
来源
关键词
health technology assessment; health equity; cost-effectiveness analysis; value elements; umbrella review; ECONOMIC-EVALUATION; PUBLIC-HEALTH; DEFINING ELEMENTS; CARE; JUSTICE; PREFERENCES; ALLOCATION; EFFICIENCY; DISEASE;
D O I
10.2147/CEOR.S471827
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cost-effectiveness analyses (CEA) are important in healthcare decision-making and resource allocation; however, expanding the scope of CEAs beyond the traditional clinicoeconomic concepts to also include value elements such as health equity has attracted much interest in recent years. This umbrella review aimed to synthesize evidence on how equity concepts have been considered in modified types of CEAs. Publicly available articles in MEDLINE were searched on January 25, 2024, to identify systematic reviews (SLRs) published in English since 2013 that incorporate health equity considerations in CEAs. Title/abstract, fulltext article screening and data extraction were conducted by a single reviewer and validated by a second reviewer. Results were qualitatively synthesized to identify common themes. Eight SLRs were included. Distributional CEAs (DCEA), equity-based weighting, extended CEA (ECEA), mathematical programming and multi-criteria decision analysis (MCDA) were the most discussed approaches. A lack of consensus on the best approach for incorporating health equity into CEAs was highlighted, as these approaches are not currently consistently used in decision-making. Important limitations included scarcity of robust data to inform health equity indices, bias associated with commonly used health outcome metrics and the challenge of accounting for additional contextual factors such as fairness and opportunity costs. Proposals to expand CEAs to address equity issues come with challenges due to data unavailability, methods complexity, and decision-makers unfamiliarity with these approaches. Our review indicates that extended and distributional CEAs can support decision-making by capturing the impact of inequity on the clinical and cost-effectiveness assessment of treatments, although future modeling should account for additional contextual factors such as fairness and opportunity costs. Recommendations for actions moving forward include standardization of data collection for outcomes related to equity and familiarity with methodologies to account for the complexities of integrating health equity considerations in CEAs.
引用
收藏
页码:581 / 596
页数:16
相关论文
共 50 条
  • [1] Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review
    Avancena, Anton L., V
    Prosser, Lisa A.
    VALUE IN HEALTH, 2021, 24 (01) : 136 - 143
  • [2] INCORPORATING EQUITY IN COST-EFFECTIVENESS ANALYSIS: A SYSTEMATIC REVIEW
    Johri, M.
    Norheim, O. F.
    VALUE IN HEALTH, 2009, 12 (07) : A230 - A230
  • [3] Using Cost-Effectiveness Analysis to Address Health Equity Concerns
    Cookson, Richard
    Mirelman, Andrew J.
    Griffin, Susan
    Asaria, Miqdad
    Dawkins, Bryony
    Norheim, Ole Frithjof
    Verguet, Stephane
    Culyer, Anthony J.
    VALUE IN HEALTH, 2017, 20 (02) : 206 - 212
  • [4] Remote Health Interventions: Effectiveness, Cost, and Cost-Effectiveness Considerations
    Williams, Austin M.
    Gift, Thomas L.
    SEXUALLY TRANSMITTED DISEASES, 2022, 49 (11S) : S15 - S17
  • [5] Considerations for Cost-Effectiveness Analysis in Oncology
    Cho, Sang Kyu
    VALUE IN HEALTH, 2021, 24 (07) : 1084 - 1085
  • [6] CAN COST-EFFECTIVENESS ANALYSIS INTEGRATE CONCERNS FOR EQUITY? SYSTEMATIC REVIEW
    Johri, Mira
    Norheim, Ole Frithjof
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (02) : 125 - 132
  • [7] Health Aid Is Allocated Efficiently, But Not Optimally: Insights From A Review Of Cost-Effectiveness Studies
    Bendavid, Eran
    Duong, Andrew
    Sagan, Charlotte
    Raikes, Gillian
    HEALTH AFFAIRS, 2015, 34 (07) : 1188 - 1195
  • [8] COST-EFFECTIVENESS ANALYSIS - A REVIEW
    RUTIGLIANO, MJ
    NEUROSURGERY, 1995, 37 (03) : 436 - 443
  • [9] EQUITY CONSIDERATIONS IN THE CALCULATION OF COST-EFFECTIVENESS IN SUBSTANCE USE DISORDER POPULATIONS
    Gilmour, Stuart J.
    ADDICTION, 2011, 106 (11) : 2047 - 2048
  • [10] METHODOLOGICAL CONSIDERATIONS IN THE ANALYSIS OF COST-EFFECTIVENESS IN DENTISTRY
    ANTCZAKBOUCKOMS, AA
    TULLOCH, JFC
    WHITE, BA
    CAPILOUTO, EI
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 1989, 49 (04) : 215 - 222